Oral Solid Dose (OSD) pharmaceutical manufacturing has long been a core capability of Avara, and we continue to invest in specialized equipment and flexible capacity to support projects across a range of product types and classifications.
We offer clinical and commercial-scale manufacturing of OSD drug product manufacturing, including potent compounds and targeted release formulations, from facilities with a long history of serving global pharma supply chains.
In line with our commitment to invest in industry best practices, Avara has expanded our OSD manufacturing capabilities to include DEA licensing for Schedule II to V controlled drugs, hot melt technology, tri-layer tablets, increased encapsulation capacity, and other custom tablet and capsule drug product manufacturing.
Each of our CMO sites provide integrated pharmaceutical contract packaging for the dosage forms they manufacture, including primary and secondary packaging services, automated inspection, specialty packaging, and serialization to international requirements.
We offer liquid and lyophilized fill-finish of sterile and aseptic injectable products, including terminal sterilization and high containment capabilities for potent compounds.